The main new drugs for the treatment of prostatitis are: cenilton, ciprofloxacin and tamsulosin, afurazosin, cilodoxime and tenizumab. These are all ongoing clinical trials. Most of these drugs are targeted at chronic prostatitis/chronic pelvic pain syndrome (i.e., prostatitis type III), and because the etiology and pathogenesis are still unclear, the treatment remains symptomatic, and the efficacy and safety of these drugs continue to be observed over the long term. As a common disease in urology, the incidence of prostatitis is increasing with the accelerated pace of modern life and changes in lifestyle habits, so the diagnosis and treatment of prostatitis still face many challenges in the future. If you have prostatitis, it is recommended to go to the hospital in time and follow the doctor’s instructions.